Micron Technology
MU
$878.84
-5.63%
Micron Technology is one of the world's largest semiconductor manufacturers, specializing in DRAM and NAND memory and storage chips sold into data centers, mobile devices, consumer electronics, and automotive/industrial markets, with a vertically integrated model spanning design through manufacturing. The company is a member of the elite global memory oligopoly alongside Samsung and SK Hynix, and its competitive identity has shifted decisively toward high-bandwidth memory (HBM) for AI accelerators, where sold-out capacity through 2027 and long-term take-or-pay contracts are reshaping its historically commodity-driven profile. The current investor narrative centers on whether AI-driven HBM demand structurally de-risks the memory cycle — bulls point to record margins, sold-out capacity, and a single-digit forward P/E, while bears flag Chinese competition from CXMT in low-end DRAM, the industry's long history of boom-bust cyclicality, and a sharp recent selloff that has knocked the stock well off its highs. Recent headlines capture this tension directly, with debate over whether 'this time is different' for memory cyclicality competing against panic-driven selling in memory and neocloud names.…
MU
Micron Technology
$878.84
Related headlines
MU 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Micron Technology's 12-month outlook, with a consensus price target around $1560.57 and implied upside of +77.6% versus the current price.
Average Target
$1560.57
0 analysts
Implied Upside
+77.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$361 - $3000
Analyst target range
Coverage is exceptionally broad with 46 analysts, and sentiment is overwhelmingly bullish: the consensus recommendation is 'strong_buy' with a mean rating of 1.37 (where 1.0 is a strong buy), and the average target price of $1,560.57 implies roughly +77.6% upside from the current $878.84. Recent institutional actions reinforce the bullish tilt — Wedbush, Baird, Rosenblatt, Wells Fargo, Citigroup, RBC, and Mizuho have all reiterated Outperform/Buy/Overweight ratings through September 2026, and New Street Research upgraded from Neutral to Buy in August. The consensus clearly leans strongly bullish, though the recent price action suggests the market is testing that conviction. The target range is extraordinarily wide — from a low of $361.00 to a high of $3,000.00 — a spread that signals very high uncertainty and divergent views on the memory cycle's durability. The $3,000 high target likely assumes sustained AI/HBM dominance, continued margin expansion, and multiple re-rating as the market accepts a structurally less cyclical Micron, while the $361 low target prices in a sharp cyclical downturn, margin compression, and Chinese competition eroding DRAM pricing. This dispersion, combined with the 2.23 beta, means investors should expect substantial volatility around the consensus view; the strong buy rating and large implied upside are compelling, but the wide range is a reminder that this remains a high-conviction, high-risk cyclical bet.
Drowning in data?
Find the real signal!
Bulls vs Bears: MU Investment Factors
The bull case currently has stronger evidence: revenue growth of 345.7% YoY, 84.6% gross margins, $26.17B TTM free cash flow, a near-zero debt load, and a 4.25x forward PE backed by a strong_buy consensus with 77.6% implied upside are concrete and verifiable, whereas the bear case rests largely on the historical pattern of memory cyclicality and a recent price decline. The single most important tension is whether AI/HBM take-or-pay contracts and sold-out capacity through 2027 genuinely break the boom-bust cycle — if they do, a 4.25x forward multiple is deeply undervalued; if margins normalize toward historical levels, current EPS estimates of $267.29 are a peak that will not recur. The 39.1% max drawdown and 2.23 beta show the market is actively debating this question through violent price swings rather than resolving it.
Bullish
- Explosive revenue acceleration, not just growth: Fiscal Q3 2026 revenue hit $41.46B, up 345.7% YoY from $9.30B and 73.8% sequentially from Q2's $23.86B. The quarterly progression ($11.32B → $13.64B → $23.86B → $41.46B) shows compounding acceleration, driven by DRAM at $18.77B versus NAND at $5.00B, confirming AI/HBM is the engine.
- Forward PE of 4.25x is extreme statistical cheapness: Trailing PE of 12.7x collapses to a forward PE of just 4.25x on estimated EPS of $267.29, implying the market is pricing in a sharp earnings normalization. Even the PEG ratio of 0.014 reflects hyper-growth expectations that are not being paid for in the multiple.
- Fortress balance sheet removes financial risk: Debt-to-equity of 0.037, current ratio of 3.31, and $25.02B in cash, with $4.75B of debt repaid in the quarter. Free cash flow TTM of $26.17B (Q3 FCF of $17.56B on $25.39B operating cash flow against $7.83B capex) means growth is entirely self-funded.
- Analyst consensus strong buy with 77.6% implied upside: 46 analysts carry a mean rating of 1.37 (strong_buy) and an average target of $1,560.57 versus the $878.84 price, implying +77.6% upside. Wedbush, Baird, Rosenblatt, Wells Fargo, Citigroup, RBC, and Mizuho all reiterated Outperform/Buy through September 2026, with New Street upgrading in August.
Bearish
- Peak-cycle margins are inherently unsustainable: Gross margin of 84.6% (up from 74.4% in Q2 and 37.7% a year ago) and operating margin of 80.4% are far above anything normal for semiconductors. Such margins invite capacity additions and competitive entry, and the market's 8.1x PS versus 4.25x forward PE signals it expects normalization, not extrapolation.
- Momentum has broken down sharply: The stock is down 5.1% over the past month versus SPY's +1.2% (relative strength -6.4%) and fell 5.6% in the latest session alone. It sits at only 64.5% of its 52-week range ($192.40 low, $1,255 high) and has suffered a 39.1% max drawdown, characteristic of a momentum unwind.
- Extreme beta and analyst target dispersion: Beta of 2.23 makes Micron more than twice as volatile as the market, and the analyst target range of $361 to $3,000 (an 8.3x spread) signals very high uncertainty on cycle durability. The $361 low target prices in a sharp downturn with margin compression and Chinese DRAM competition.
- CXMT competition threatens low-end DRAM pricing: Chinese competitor CXMT's expansion in commodity DRAM is the proximate trigger for the recent selloff. While bulls argue the threat is confined to low-end DRAM, any pricing spillover into mainstream DRAM would pressure the $18.77B quarterly DRAM revenue base that drives the entire thesis.
MU Technical Analysis
Micron is in a powerful, sustained uptrend that has begun to consolidate: the stock is up 333.9% over the past year and 178.6% year-to-date, dwarfing the S&P 500's 15.5% and 11.9% respective gains. At $878.84, the stock sits at roughly 64.5% of its 52-week range (low of $192.40, high of $1,255.00), meaning it has surrendered a meaningful portion of its peak even as the longer-term trend remains decisively higher. This positioning signals a high-momentum name undergoing a sharp corrective phase rather than a broken uptrend — the stock is neither near overextended highs nor near the falling-knife lows. Recent momentum has deteriorated markedly: the stock is down 5.1% over the past month versus a 1.2% gain for SPY (relative strength of -6.4%), and down 5.6% in the latest session alone, while the 3-month change of +3.5% barely edges SPY's +2.7%. This divergence — a strongly positive 6-month (+93.1%) and 1-year trend colliding with negative 1-month momentum — is characteristic of a momentum unwind or mean-reversion pullback within a larger uptrend, and the 39.1% max drawdown underscores how violently this name corrects. Key levels are clear: the $1,255 52-week high is the resistance that a breakout would need to clear to reassert the uptrend, while the $192.40 52-week low is distant support; nearer-term, the recent swing lows around $739 (late July) and the $820-$850 zone are the levels to watch, and a breakdown below them would signal the correction deepening. With a beta of 2.23, Micron is more than twice as volatile as the market, which demands smaller position sizing and wider stops; the 1.04 short ratio and 30.3 million share volume suggest no unusual bearish positioning, but the elevated beta means headline-driven swings (like the CXMT competition fears) can move the stock 5%+ in a single session.
Beta
2.23
2.23x market volatility
Max Drawdown
-39.1%
Largest decline past year
52-Week Range
$192-$1255
Price range past year
Annual Return
+333.9%
Cumulative gain past year
| Period | MU Return | S&P 500 |
|---|---|---|
| 1m | -5.1% | +0.2% |
| 3m | +3.5% | +2.9% |
| 6m | +93.1% | +8.4% |
| 1y | +333.9% | +14.9% |
| ytd | +178.6% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MU Fundamental Analysis
Micron's revenue trajectory is nothing short of explosive: fiscal Q3 2026 (quarter ended May 28, 2026) revenue hit $41.46 billion, up 345.7% year-over-year from $9.30 billion in the year-ago quarter, and up 73.8% sequentially from Q2's $23.86 billion. The multi-quarter progression — $11.32B (Q4'25), $13.64B (Q1'26), $23.86B (Q2'26), $41.46B (Q3'26) — shows growth not just accelerating but compounding at a staggering rate, driven overwhelmingly by DRAM ($18.77B in the quarter) versus NAND ($5.00B), consistent with the AI/HBM demand surge. This is a textbook memory upcycle supercharged by AI, and the segment mix confirms Micron's high-value DRAM/HBM exposure is the engine of the investment case. Profitability has expanded to extraordinary levels: Q3 net income of $28.24 billion produced a 68.1% net margin, gross margin reached 84.6% (up from 74.4% in Q2 and just 37.7% in the year-ago quarter), and operating margin hit 80.4%. These margins are far above anything typical for the semiconductor industry and reflect severe supply-demand imbalance in memory; the risk is that such margins are inherently cyclical and invite capacity additions and competition. The balance sheet is fortress-like: debt-to-equity of just 0.037, a current ratio of 3.31, and $25.02 billion in cash at quarter-end. Free cash flow is robust at $26.17 billion TTM, with Q3 FCF of $17.56 billion on operating cash flow of $25.39 billion against $7.83 billion of capex, and ROE of 61.4% and ROA of 44.6% are exceptional; the company is self-funding its growth and even repaid $4.75 billion of debt in the quarter, leaving minimal financial risk.
Quarterly Revenue
$41.5B
2026-05
Revenue YoY Growth
+345.7%
YoY Comparison
Gross Margin
84.6%
Latest Quarter
Free Cash Flow
$26.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MU Overvalued?
Because Micron is solidly profitable (Q3 net income of $28.24 billion), the PE ratio is the appropriate primary metric. The trailing PE of 12.7x against a forward PE of just 4.25x is a dramatic gap that implies the market expects earnings to continue surging — forward EPS estimates of $267.29 versus the trailing figure suggest analysts anticipate another massive step-up in profitability, and the PEG ratio of 0.014 reflects that hyper-growth expectation. The forward multiple of ~4.3x is remarkably cheap for a company posting triple-digit revenue growth, though the market's skepticism about cycle durability is precisely why it trades there. On peer comparison, Micron's 8.1x PS and 7.8x P/B are elevated versus its own history but the 4.25x forward PE and 9.6x EV/EBITDA sit below typical semiconductor-sector multiples for high-growth names; the discount reflects the market's cyclicality discount rather than any deficiency in current fundamentals, and whether that discount is justified hinges entirely on the durability of AI memory demand. Historically, Micron's PE has ranged from negative (loss years) to the 8-16x range in profitable periods, and its PS ratio has ranged from ~9x to over 25x; the current 8.1x PS is near the lower end of its recent band even as absolute earnings hit records, suggesting the market is pricing in a normalization of margins rather than extrapolating the current 84.6% gross margin. In short, the stock looks statistically cheap on forward earnings but expensive on sales and book relative to its own history — a classic late-cycle memory valuation pattern where the market pays little for peak earnings.
PE
12.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 8x~16x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the sustainability of peak-cycle profitability. Gross margin of 84.6% and operating margin of 80.4% are extraordinary for semiconductors and reflect a severe supply-demand imbalance that historically self-corrects as capacity is added; a normalization toward the 37.7% gross margin seen a year ago would devastate earnings power. Revenue is heavily concentrated in DRAM ($18.77B of $41.46B in Q3), and within that, AI/HBM demand is the swing factor, so any deceleration in AI accelerator orders would hit the largest and highest-margin segment directly. The offsetting strength is a fortress balance sheet — debt-to-equity of 0.037, current ratio of 3.31, $25.02B cash, and $26.17B TTM free cash flow — which means the risk is earnings volatility, not solvency.
Market and competitive risks are dominated by valuation compression and Chinese competition. At 8.1x PS and 7.8x P/B, the stock is expensive on sales and book relative to its own history, and the 4.25x forward PE only looks cheap if peak EPS of $267.29 is durable; if the market re-rates toward a mid-cycle multiple, the stock could fall sharply even with stable earnings. CXMT's expansion in commodity DRAM is the proximate cause of the recent selloff, and while bulls argue it is confined to low-end DRAM, any pricing spillover would pressure the core DRAM franchise. With a beta of 2.23, Micron amplifies every macro and sector-rotation move, and the -6.4% one-month relative strength versus SPY shows how quickly sentiment can turn.
Worst-case scenario: AI capex digestion slows, HBM contract pricing resets at renewal, CXMT gains share in mainstream DRAM, and margins compress toward historical mid-cycle levels, causing forward EPS estimates to be cut dramatically. In that chain, the stock could retest the analyst low target of $361.00, which is roughly -59% from the current $878.84, and in a severe cycle the 52-week low of $192.40 (-78%) is not unthinkable given the 39.1% max drawdown already experienced. A realistic adverse case is a decline to the $361-$500 zone, a loss of 43% to 59% from current levels, which is why position sizing must account for the 2.23 beta.